Gout
245
21
31
158
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Published Results
60 trials with published results (24%)
Research Maturity
158 completed trials (64% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.1%
10 terminated out of 245 trials
94.0%
+7.5% vs benchmark
21%
52 trials in Phase 3/4
38%
60 of 158 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 158 completed trials
Clinical Trials (245)
A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants
Drug-Drug Interaction Study of ABP-671 in Gout Patients
A Therapeutic Confirmatory Study of Epaminurad Versus Febuxostat in Gout Patients
A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every 2 Weeks (Q2W) With MTX in Participants With Uncontrolled Refractory Gout
Tight Control of Gouty Arthritis Compared to Usual Care
The Orienting Study
Tigulixostat (IBI128) vs Febuxostat in Gout
The Remote Monitoring of Gout Feasibility Study in Primary Care
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare
Phone-Based Based Walk With Ease Program for Adults With Arthritis
Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines - (DREAM) Probenecid vs Allopurinol
A Study to Investigate the Clinical Effect and the Safety of PRX-115 Infused Intravenously at Different Dosing Regimens, With and Without Methotrexate, Versus Placebo in Adults Gout Patients (RELEASE)
Time Required to Dissolve Urate Deposits
Pharmacist-Led Treat-to-Target Urate Lowering Therapy in Patients With Gout
Treat-to-target by Email During Urate-lowering Therapy in Gout
Anakinra vs Prednisone to Treat Gout Flare in Patients With Chronic Kidney Disease Stage 4/5 or Renal Transplantation
Immediate Prescription of a Hypouricemic Treatment, Febuxostat, Compared to Its Delayed Administration
Purified Cortrophin® Gel Efficacy and Safety Study of 2 Dose Levels in Patients With Acute Gout Flares